Core Viewpoint - The news highlights significant earnings growth for various companies in 2025, alongside notable corporate actions such as stock repurchases and control changes [1][2][3]. Earnings Highlights - Haiguang Information expects a net profit increase of 22.56% to 42.32% year-on-year for Q1 2026, with projected revenues between 39.1 billion to 42.2 billion yuan, reflecting a growth of 62.91% to 75.82% [3][23]. - Nanya New Materials reported a staggering net profit growth of 378.65% in 2025, with total revenues of 52.28 billion yuan, up 55.52% [5][25]. - Eco-Optoelectronics achieved a net profit increase of 307.63% in 2025, with revenues of 4.4 billion yuan, marking a 77.36% growth [5][25]. - Shengen Co. saw a net profit rise of 146.54% in 2025, with revenues of 4.43 billion yuan, up 46.26% [6][26]. - Qingda Environmental reported a net profit growth of 94.62% in 2025, with revenues of 20.42 billion yuan, reflecting a 55.42% increase [6][26]. - Huachuang Technology's net profit grew by 89.45% in 2025, with revenues of 6.28 billion yuan, up 2.78% [7][27]. - Xinchun Micro-Assembly reported a net profit increase of 80.42% in 2025, with revenues of 14.08 billion yuan, up 47.61% [7][27]. - Union Medical's net profit grew by 49.6% in 2025, with revenues of 138.21 billion yuan, up 34.18% [8][28]. - Xindong Link's net profit increased by 36.1% in 2025, with revenues of 5.24 billion yuan, up 29.48% [8][28]. - Honghua Digital Science reported a net profit growth of 27.63% in 2025, with revenues of 23.08 billion yuan, up 28.9% [9][29]. - Zhujiang Beer achieved a net profit increase of 11.42% in 2025, with revenues of 58.78 billion yuan, up 2.56% [9][29]. Corporate Actions - Wens Foodstuff Group plans to repurchase shares worth between 8 billion to 12 billion yuan, with a maximum price of 24 yuan per share [4][24]. - Zhiyang Innovation terminated its major asset restructuring plans and will resume trading on February 26, 2026 [10][30]. - Huylong New Materials and Falan Technology are planning control changes, leading to a trading suspension starting February 26, 2026 [2][22]. - ST Xinhuajin is under investigation by the China Securities Regulatory Commission for information disclosure violations, leading to a trading suspension [12][32]. - Da Yuan Pump Industry announced the passing of one of its actual controllers, which may affect the company's ownership structure [14][34]. - Shandong Haohua plans to invest 48.37 billion yuan in a soda ash facility upgrade for energy efficiency and environmental protection [14][34]. - Yancoal Australia reported a tax profit of 4.4 million AUD for 2025, with total revenues of 59.49 billion AUD [15][35]. - Baibang Technology renewed its independent repair provider agreement with Apple, extending the contract to June 30, 2030 [15][35]. - Zhiguang Electric's subsidiary won a bid for a 1.82 billion yuan project with the Southern Power Grid [16][36]. - Jinpu Titanium's subsidiary resumed production after a temporary halt due to market conditions [16][36].

Group 1: Real Estate Policy Changes - Shanghai has implemented a new notification to optimize and adjust the city's real estate policies, effective from February 26, which includes reducing housing purchase restrictions for non-local residents and allowing them to buy additional properties in certain areas [1][5] - The notification also optimizes housing provident fund policies [1] Group 2: Company Earnings Reports - Sainuo Medical reported a total revenue of 525 million yuan for 2025, a year-on-year increase of 14.53%, and a net profit of 47.29 million yuan, showing a significant growth of 3057.05% [5][6] - Haiguang Information achieved a revenue of 14.376 billion yuan in 2025, up 56.91%, with a net profit of 2.542 billion yuan, increasing by 31.66% [5] - Nanya New Materials reported a net profit of 241 million yuan for 2025, a growth of 378.65% [6] - Aibo Medical plans to acquire 68.31% of Demai Medical for 683 million yuan, aiming to enhance its position in the health sector [6][7] Group 3: Market Developments - The Hong Kong government has announced plans to revise listing requirements for companies with dual-class shares and to facilitate the listing process for biotech firms [2][3] - The sales of home appliances and digital products during the recent Spring Festival reached 5.106 million units, a 21.7% increase compared to the previous year, with offline sales accounting for 73.3% of total sales [4] Group 4: Corporate Actions - Wens Foodstuff Group plans to repurchase shares worth between 800 million to 1.2 billion yuan at a maximum price of 24 yuan per share [8] - ST Xinhua Jin has received a notice from the China Securities Regulatory Commission regarding an investigation for information disclosure violations, leading to a temporary suspension of its stock [9] - Gree Electric Appliances' largest shareholder plans to reduce its stake by up to 2% through block trading to repay bank loans, without affecting control of the company [10] Group 5: Industry Insights - A report from CITIC Securities indicates that the demand for AI data centers (AIDC) is expected to grow rapidly, with a compound annual growth rate of approximately 55% from 2025 to 2028, leading to significant opportunities in the power supply sector [10]

一、2025年年度主要财务数据和指标 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 本公告所载2025年度主要财务数据为初步核算数据，未经会计师事务所审计，具体数据以上海联影医疗 科技股份有限公司（以下简称"公司"）2025年年度报告为准，提请投资者注意投资风险。 单位：人民币万元 2.以上财务数据及指标以合并报表数据填列，但未经审计，最终结果以公司2025年年度报告为准。 二、经营业绩和财务状况情况说明 （一）报告期的经营情况、财务状况及影响经营业绩的主要因素 1、经营情况、财务状况 公司2025年度实现营业总收入1,382,064.02万元，同比增长34.18%；实现归属于母公司所有者的净利润 188,779.84万元，同比增长49.60%；实现归属于母公司所有者的扣除非经常性损益的净利润178,834.08 万元，同比增长77.01%。 2025年末，公司总资产3,280,039.60万元，同比增长17.00%；归属于母公司的所有者权益2,159,024.54万 元，同比增长8.48%。 2、影响经营业绩的主要因素 ...

2月25日晚，智洋创新公告称，公司此前筹划以发行人民币普通股股票、定向发行可转换公司债券（如 有）、支付现金（如有）等方式购买深圳市灵明光子科技有限公司（简称"灵明光子"）控股权，同时拟 募集配套资金。因交易双方未能就交易核心条款达成一致意见，经审慎研究，公司决定终止筹划本次重 大资产重组事项。公司股票自2月26日开市起复牌。 虽然重组止步，但智洋创新选择了另一种方式入股灵明光子，并有望与之开展深度合作。 智洋创新公告称，公司与灵明光子签署《战略投资意向协议》，拟以现金向灵明光子进行增资及购买部 分股权（如有），投资金额初步暂定为3.00亿元。灵明光子投前估值水平初步暂定为27亿元至30亿元。 智洋创新投后持股比例为9.09%至10.00%。 智洋创新预计有权提名一名灵明光子的董事候选人，并拥有灵明光子的整体出售否决权。 第二，在智洋创新采纳灵明光子设计制造的激光雷达芯片及模组的前提下，由智洋创新向灵明光子采购 激光雷达芯片及模组，并应用于智洋创新的雷视一体化产品上。 灵明光子是国内高质量dToF（直接飞行时间）传感芯片及系统解决方案提供商，致力于帮助智能终 端、激光雷达（LIDAR）、智能驾驶与消费电子实现 ...

| | | 【2月25日晚间重要公告一览】 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 业绩精选 | 海光信息 | 李度净利润同比预增22.56%-42.32% | | | 南亚新材 | 业绩快报:2025年度净利润同比增长378.65% | | | 埃科光电 | 业绩快报:2025年度净利润同比增长307.63% | | | 神工股份 | 业绩快报:2025年度净利润同比增长146.54% | | | 青达环保 | 业绩快报:2025年度净利润同比增长94.62% | | | 华强科技 | 业绩快报:2025年度净利润同比增长89.45% | | | 芯春微装 | 业绩快报:2025年度净利润同比增长80. 42% | | | 联影医疗 | 业绩快报:2025年度净利润同比增长49.6% | | | 心动联科 | 业绩快报:2025年度净利润同比增长36.1% | | | 宏华数科 | 业绩快报:2025年度净利润同比增长27.63% | | | 珠江啤酒 | 业绩快报:2025年度净利润同比增长11.42% | | 定增&重组 | 智洋创新 | 终止筹划重大资产重 ...

截至2026年2月25日收盘，联影医疗（688271）报收于127.45元，较前一交易日上涨0.29%，最新总市值 为1050.39亿元。该股当日开盘127.08元，最高128.55元，最低126.32元，成交额达4.88亿元，换手率为 0.46%。 《联影医疗2025年度业绩快报公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 近日，上海联影医疗科技股份有限公司发布2025年度业绩快报，营业总收入1,382,064.02万元，同比增 长34.18%；归属于母公司所有者的净利润188,779.84万元，同比增长49.60%。扣除非经常性损益的净利 润同比增长77.01%。总资产3,280,039.60万元，同比增长17.00%；归属于母公司的所有者权益 2,159,024.54万元，同比增长8.48%。业绩增长主要受益于创新产品推出、高端产品市场认可度提升、国 内外市场拓展及国内医疗设备更新政策落地。 最新公告列表 ...

每经记者｜王帆 每经编辑｜陈柯名 魏文艺 ST西发：拟现金购买拉萨啤酒50%股权 2月25日，ST西发公告称，公司拟以现金购买嘉士伯国际所持拉萨啤酒50%股权，完善资产完整性，提 升竞争力。 业绩披露 联影医疗：2025年归母净利润同比增长49.60% 2月25日，联影医疗发布2025年度业绩快报，营业总收入达到138.2亿元，同比增长34.18%；归母净利润 为18.88亿元，同比增长49.60%。 传音控股：2025年归母净利润同比下降53.43% 记者|王帆 编辑|陈柯名 魏文艺 杜恒峰 校对|程鹏 股份收购 格力电器：第一大股东拟减持不超2%公司股份 2月25日，传音控股发布业绩快报，2025年实现营业总收入656.23亿元，同比下降4.5%；归母净利润 25.84亿元，同比下降53.43%。 华峰测控：2025年归母净利润同比增长61.22% 2月25日，华峰测控发布业绩快报，2025年实现营业总收入13.46亿元，同比增长48.72%；归母净利润 5.38亿元，同比增长61.22%。 海光信息：2025年营收和归母净利润同比双增 2月25日，海光信息发布业绩快报，2025年实现营业总收入143.7 ...

2月25日晚间，联影医疗（688271.SH）发布2025年度业绩快报。公司2025年实现营业总收入138.21 亿元，同比增长34.18%；归母净利润18.88亿元，同比增长49.60%；扣非归母净利润17.88亿元，同比增 长77.01%。 报告期内，联影医疗在国内市场占有率持续提升并保持行业领先地位，中国市场收入规模实现显著 增长，经营质量与盈利能力同步增强。海外市场方面，公司在欧洲、北美、亚太以及新兴市场等重点区 域均保持较快增长节奏，国际市场品牌影响力与高端客户渗透率持续提升，全球化布局进一步提速。 （王珞） ...

Major Announcements - SMIC's application for issuing shares to purchase assets has been accepted by the Shanghai Stock Exchange [2] - Gree Electric's largest shareholder plans to reduce its stake by no more than 2% [35] - Haiguang Information expects a net profit increase of 22.56% to 42.32% in Q1 2026 [18] Company Developments - SMIC plans to issue shares to acquire 49% of the equity in Zhongke North Integrated Circuit Manufacturing [2] - Bona Film Group reports normal operations with no significant changes in the internal and external business environment [2] - ST Xinhua Jin is under investigation by the CSRC for information disclosure violations [3] - Shandong Haihua plans to invest 48.37 billion yuan in a soda ash facility upgrade for energy efficiency [4] - ST Yanshi warns of potential delisting risks due to significant stock price fluctuations and unresolved audit issues [5] - Saifutian's subsidiary has resumed production, stabilizing the supply of photovoltaic battery products [6] - Jin'an Guoji's subsidiary has been recognized as a high-tech enterprise, benefiting from tax incentives [7] - Chuanjinno reports market rumors regarding U.S. national security priorities affecting its operations [8] - Lingyi Zhi Manufacturing plans to invest in a fund focused on advanced equipment manufacturing [9] - Songsheng Co. is establishing a joint venture for digital energy products [10] - Longbai Group's subsidiary has partially resumed production after safety inspections [10] - Tongyuan Petroleum reports no significant changes in its business environment despite stock price fluctuations [11] Financial Performance - Haiguang Information's 2025 revenue reached 14.376 billion yuan, a 56.91% increase, with a net profit of 2.542 billion yuan, up 31.66% [18] - Sainuo Medical's 2025 revenue was 525 million yuan, a 14.53% increase, with a net profit of 47.286 million yuan, up 3057.05% [19] - Koweil's 2025 revenue was 514 million yuan, a 7.39% increase, with a net profit of 64.8996 million yuan, up 32.32% [20] - United Imaging's 2025 revenue reached 13.821 billion yuan, a 34.18% increase, with a net profit of 1.888 billion yuan, up 49.6% [21] - Nanya New Materials reported a 2025 net profit of 241 million yuan, a 378.65% increase [22] - Yanzhou Coal's Australian subsidiary reported a 2025 after-tax profit of 440 million AUD [23] - Lante Optical's 2025 net profit was 388 million yuan, a 76.09% increase [24] - Huafeng Measurement's 2025 net profit was 538 million yuan, a 61.22% increase [26] - Hancable's 2025 net profit was 592 million yuan, a 9.59% decrease [27] - Transsion Holdings reported a 2025 net profit of 2.584 billion yuan, a 53.43% decrease [27] - Aiko Optoelectronics reported a 2025 net profit of 64.0919 million yuan, a 307.63% increase [28] - Huachuang Technology's 2025 net profit was 42.678 million yuan, an 89.45% increase [29] - Honghua Digital's 2025 net profit was 529 million yuan, a 27.63% increase [29] - Zhujiang Beer reported a 2025 net profit of 903 million yuan, an 11.42% increase [30] - Xindong Lian Ke's 2025 net profit was 302 million yuan, a 36.1% increase [31] - Qingda Environmental's 2025 net profit was 181 million yuan, a 94.62% increase [33] - Shenkong Co.'s 2025 net profit was 101 million yuan, a 146.54% increase [34] - Chip Micro's 2025 net profit was 290 million yuan, an 80.42% increase [34]

本报讯 2月25日晚间，上海联影医疗科技股份有限公司（以下简称"联影医疗"）发布2025年度业绩快 报。数据显示，2025年，联影医疗实现营业总收入138.21亿元，同比增长34.18%；归母净利润18.88亿 元，同比增长49.60%；扣非归母净利润17.88亿元，同比增长77.01%。 联影医疗表示，未来随着创新产品在全球市场加快导入、重点项目陆续交付、客户基础进一步扩张，以 及全球本土化组织与服务体系日益成熟，公司将进入技术创新驱动增长、智能化管理提升效率、全球化 协同放大规模优势的新阶段，整体经营规模与运营质效有望进一步稳健提升。 2025年，联影医疗在国内市场占有率持续提升并保持行业领先地位，中国市场收入规模实现显著增长， 经营质量与盈利能力同步增强。海外市场方面，公司在欧洲、北美、亚太以及新兴市场等重点区域均保 持较快增长节奏，国际市场品牌影响力与高端客户渗透率持续提升，全球化布局进一步提速。 （文章来源：证券日报） 作为国产高端医疗设备龙头企业，2025年，联影医疗先后实现中国首款光子计数能谱CT uCTUltima、 世界首台"摄像"磁共振uMR Ultra等重磅产品获批上市，在此基础上，该公 ...